Multi-omics Quality Assessment in Personalized Medicine Through European Infrastructure for Translational Medicine (EATRIS): An Overview
Authors:
- EATRIS-Plus Multi-omics working group and StakeholdersESEATRIS-Plus Multi-omics working group and Stakeholders
- Patricia Alonso-AndrésPAPatricia Alonso-Andrés
- Davide BaldazziDBDavide Baldazzi
- Qiaochu ChenQCQiaochu Chen
- Elisa Conde MorenoEMElisa Conde Moreno
- Lorena Crespo-ToroLCLorena Crespo-Toro
- Kati DonnerKDKati Donner
- Petr DžubákPDPetr Džubák
- Sara EkbergSESara Ekberg
- Maria Laura García BermejoMBMaria Laura García Bermejo
- Daniela GasparottoDGDaniela Gasparotto
- Bishwa GhimireBGBishwa Ghimire
Open Access
- 1 April 2025
- journal article
- review article
- Published by Springer Nature in Phenomics
- Vol. 5 (3) , 311-325
Abstract
Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (www.EATRIS.eu), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activities of member facilities of EATRIS towards quality assessment of pre-clinical sample processing, clinical omics data generation, multi-omics data integration, and dissemination of the resources in a Multi-Omics Toolbox, which is the principal deliverable of the EATRIS-Plus project for the consolidation of EATRIS towards translational medicine.Keywords
Funding Information
- Horizon 2020 Framework Programme (871096)
- University of Helsinki
This publication has 57 references indexed in Scilit:
- Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial IntelligenceInformation Fusion, 2023
- Corrigendum to “Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds” [Heliyon 8 (9), (September 2022) e09616]Heliyon, 2022
- External Quality Assurance programs for processing methods provide evidence on impact of preanalytical variablesNew Biotechnology, 2022
- Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosisEBioMedicine, 2022
- Multiomics and digital monitoring during lifestyle changes reveal independent dimensions of human biology and healthCell Systems, 2022
- Towards quality assurance and quality control in untargeted metabolomics studiesMetabolomics, 2019
- ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificityJournal of Proteomics, 2015
- Interlaboratory studies and initiatives developing standards for proteomicsProteomics, 2013
- The ABRF Proteomics Research Group Studies: Educational exercises for qualitative and quantitative proteomic analysesProteomics, 2011
- The role of proficiency testing in method validationAccreditation and Quality Assurance, 2009